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This study was carried out to determine the persistence of toxicity of fermentation extracts of Bacillus thuringiensis var. israelensis
after more than three decades of storage. For this purpose, a population of Aedes aegypti was established. The mortality rate of
20 spore-crystal extracts purified using the acetone-lactose coprecipitation method was measured and evaluated by bioassays
according to a modified WHO protocol. The extracts with the highest mortality rate were determined in triplicate by their LD
50
and LD
98
. All extracts showed toxicity at the highest tested dose (1000 ppm) and some, such as strains 3260 and 3501, still killed
larvae at doses as low as 0.01 ppm.These data are surprising because no study on the activity of B. thuringiensis toxic proteins after
such a long storage time has been reported.
1. Introduction
Mosquitoes today represent one of the most serious threats
to public health because of their hematophagous nature and
vector capacity. Some genera, such as Aedes, Anopheles, and
Culex, transmit pathogens and parasites (viruses, protozoa, or
nematodes) that cause devastating diseases such as dengue,
Zika, chikungunya, encephalitis, yellow fever, malaria, and
elephantiasis, which together are responsible for high mor-
bidity and mortality in billions of people spread over almost
half of the planet [1–6].
The need for more environmentally friendly insecticides
and the increased resistance to chemicals have provided an
excellent opportunity to eradicate mosquitoes with biological
products based on Bacillus thuringiensis var. israelensis (Bti).
These bacteria conserve parasporal crystals and spores of
the H-14 serotype, which when ingested by mosquito larvae
are solubilized in the alkaline environment of the midgut.
This leads to the activation of insecticidal proteins of the
crystal which bind to receptors in the cell wall and form
intestinal pores that result in larvae death. This insecticidal
effect is produced by four toxins known as Cry4A, Cry4B,
Cry11Aa, and Cyt1A. Their main attributes are high toxicity
and specificity towards family Culicidae [7–9].
Since its discovery and description by Goldberg andMar-
galit [10], Bti has shown remarkable effectiveness in killing
mosquitoes, in contrast to its innocuousness to humans
and other mammals, aquatic vertebrates, invertebrates, and
plants. Because of these characteristics, commercial prepara-
tions of these bacteria have been chosen for mosquito control
programs [11–14]. Dulmage et al. [15] were among the most
important pioneers in the development of technologies for
the implementation of Bti as a biological pest control agent.
They established diverse methodologies for mass production,
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Figure 1: Diagram of experimental procedure.
product formulation, and power standardization. From these
processes, several hundred fermentation extracts of cultures
belonging to this microorganism, characterized by their
insecticidal activity against Dipteran, were donated by the
United States Department of Agriculture in 1989 to our
research group. Since then, these extracts have been kept
in the Universidad Auto´noma de Nuevo Leon (UANL)
International Collection of Entomopathogenic Bacilli. Partic-
ularly important within this collection are 20 fermentation
extracts, which we decided to utilize in this research to prove
their ability to kill mosquitoes under laboratory conditions
through their residual activity.
2. Materials and Methods
2.1. Bti Strains. Bti fermentation extracts from the collec-
tion of Dulmage et al. [15] recovered by lactose-acetone
coprecipitation during the period from 1978 to 1983 were
chosen. During this period, the extracts were stored in the
dark in a dry space exclusively for this purpose at 25 ± 3∘C
in sterile and hermetic bottles. Twenty-four samples of the
strain HD-500 and twenty-five of HD-567 were observed
under the microscope with a simple Coomassie blue stain to
ascertain the absence of contamination (Figure 1). They were
then activated in Petri dishes and incubated in BD Bioxon
nutrient agar for 72 hours to demonstrate their viability and,
subsequently, samples that displayed viability were selected.
2.2. Mosquitoes. The larvae of the third and fourth instars of
A. aegypti used in these experiments were obtained from the
insectary of the Institute of Biotechnology of the School of
Biology of the UANL. This mosquito colony is permanently
maintained under pathogen-free conditions at 28 to 30∘C
with 60 to 80% relative humidity and light/dark cycles of
12 h. Under these conditions, the cycle from egg to adult is
completed in three to four weeks. The larvae were fed daily
with finely ground presterilized dog food (Pedigree brand).
The pupae were removed daily to control the age of the
mosquito and placed in a container that was introduced into
a cage for 48 h for the emergence of adult mosquitoes. Cages
of different sizes were used according to the magnitude of
the mosquito population, which was fed daily with a 10%
glucose solution soaked in cotton swabs and every 3 days
with a blood source for 10min. Oviposition of the females
was stimulatedwith an ovitrap consisting of a water container
covered with brown paper. Collected eggs were transferred to
trays to perpetuate the cycle in such a way that larvae used in
all the experiments were available.
2.3. Standard Preparation. As a positive control (100% mor-
tality), a primary standard was prepared from VectoBac
3000UTI/mg (Valent BioSciences Corp. Libertyville, IL) at
a concentration of 0.05 ppm. This was placed in Petri dishes
with nutritive agar. Broth was taken and transferred to nutri-
ent broth and incubated at 30∘C at 150 rpm for 12 hours until
an optical density greater than 1 (2 × 108 CFU/ml), measured
with a spectrophotometer at a wavelength of 540 nm, was
reached. An aliquot of 1ml in triplicate was added to 500ml
Erlenmeyer flasks with 100ml of Bti medium (unpublished
experimental medium) to verify the potency of the extracts.
Distilled water was used as a negative control (Figure 1).
International Journal of Microbiology 3
2.4. Bioassays. TheWorldHealthOrganization guidelines for
laboratory bioassays of bacterial larvicideswere followed [16].
Suspensions of each fermentation extract were prepared at
2000 ppm in Erlenmeyer flasks. Dilutions were then made to
obtain final concentrations of 1000, 100, 10, 1, 0.1, and 0.01,
respectively. Transparent plastic cups with 250ml capacity
were used with 150ml per vessel and 25 larvae of the second
or third stage were added (Figure 1). To calculate LD
50
of
the fermentation extracts, three suspensions of 2%, 50%, and
98% were prepared. The positive control was performed in
duplicate with the primary standard. Results were tabulated
according to dose, considering the number of live and dead
mosquitoes with 4 replications per treatment performed in
triplicate at 24 hours. To calculate LD
50
, a linear regression
was applied using the R statistical package, 2015 [17]. Bioas-
says were carried out at least three times and the validity of
the results was evaluated with the primary extract obtained
from VectoBac.
3. Results
Of the 49 Bti fermentation extracts from the collection, only
20 still contained spores as protein crystals; therefore, only
these were used in the bioassays. Dead larvae were counted
every 6 hours during a 24-hour period (Table 1). In this
case, dying larvae were included to calculate the mortality
rate. Most of these Bti extracts showed some toxic activity
towards mosquito larvae in high concentrations, but their
activity decreased as the dilution increased (Table 1). Thus,
at 1000 ppm, up to 18 extracts managed to kill larvae to
some degree; in fact, 10 extracts were 100% effective. This
same trend was observed at 100 ppm, where only the extract
from strain 3299 was unable to kill all test insects, but at
10 ppm only 5 of the extracts maintained this potency. An
interesting fact was observed for the extract of strain 3260.
Even at concentrations of 1 and 0.1, it maintained its toxic
activity unaltered to kill all of the larvae. However, at a
higher dilution (0.01 ppm), the extractwas unable tomaintain
its residual activity (Figure 2). It is worth noting that the
toxic activity of both the commercial product, VectoBac,
and the laboratory preparation produced from it (VA) was
maintained even at the lowest concentrations under our
experimental conditions and together with strains 3260 and
3501 also showed a consistent ability to kill mosquito larvae at
the lowest concentrations. Thus, LD
50
and LD
98
were 0.01 ±
0.0 and 0.11 ± 0.01; 0.12 ± 0.0 and 1.07 ± 0.09; and 1.16 ± 0.02
and 3.6 ± 0.14 ppm for VectoBac, 3260, and 3501, respectively
(Figure 3).
4. Discussion
Our findings demonstrate the persistence of toxic activity
of fermentation extracts of Bti against A. aegypti after three
decades of storage. All extracts studied showed toxicity at
the highest tested doses (1000 ppm) and some of the extracts,
from strains 3260 and 3501, still killed larvae at doses as low
as 0.01 ppm. Such data are surprising, since no study to date
has reported the activity ofB. thuringiensis toxic proteins after
0
20
40
60
80
100
20
0
40
60
80
100
20
40
60
80
100
0
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
32
60VAVC 35
01
36
91
36
96
37
56
33
53
35
05
38
57
37
79
32
99
38
25
35
52
38
24
33
56
35
53
35
49
28
58
33
50
38
26
38
59
M
or
ta
lit
y 
(%
)
Fermentation extract code
1000 ppm
100 ppm
10 ppm
1.0 ppm
0.1 ppm
0.01 ppm
Figure 2: Toxicity of Bacillus thuringiensis var. israelensis fermenta-
tion extracts at different concentrations against Aedes aegypti (VC,
commercial VectoBac; VA, activated VectoBac).
such a long storage time. On the other hand, the few reports
on the persistence of toxicity in the field or under controlled
conditions indicate that these proteins quickly lose their
insecticidal properties due to different causes. Among the
environmental factors that negatively affect the persistence
of toxicity are temperature [18], solar radiation [19], pH [20],
and organic matter [21]. However, other authors have shown
that some conditions favor the possibility of increasing their
persistence. For example, Saxena et al. [22] showed that
Cry proteins from Bt maize root exudates maintained their
larvicidal activity for more than 180 days in soil, while Tapp
and Stotzky [23] reported this same toxic capacity more than
234 days after their incorporation into soil. This is probably
a result of their binding to the clay particles of the porous
matrix. In our case, the Bti protein crystals of the tested
extracts were covered for more than three decades with the
lactose matrix used during obtention of the fermentation
extract.This suggests the important role that this disaccharide
could have in maintaining the activity of the toxic proteins
of the different Bti strains particularly stable after this period
of time. In other varieties of this bacterium from the same
collection of fermentation extracts (unpublished data), whose
protective mechanism is still uncertain, the same effect does
not appear. Although the activity of the extracts of Bti was
found to be very low compared to treatment with VectoBac,
it is notable that most maintained residual activity at the
highest concentrations tested, and two of these extracts stood
out at the minimum concentrations at which they could
kill mosquito larvae. This is an encouraging sign regarding
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Figure 3: LD
50
and LD
98
of fermentation extracts 3501 and 3260
from Bacillus thuringiensis var. israelensis.
the possibility of improving the use of special strains and
improved formulations to control insect vectors of diseases.
5. Conclusions
Fermentation extracts from Bacillus thuringiensis var. israe-
lensis maintained their residual toxic activity against Aedes
aegypti larvae after storage at 25 ± 3∘C in the aforementioned
conditions for more than three decades. Extracts 3260 and
3501 showed LD
50
of 0.12 and 1.16 ppm, respectively. This
work demonstrates that Bti protein crystals can prolong
their toxicity in shelf life or field conditions under specific
conditions.
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